GC Wealth Management RIA LLC Acquires Shares of 1,713 Becton, Dickinson and Company $BDX

Key Points

• GC Wealth Management RIA LLC acquired 1,713 shares of Becton, Dickinson and Company ($BDX), valued at approximately $295,000, during the 2nd quarter.
• Becton, Dickinson reported a quarterly earnings per share (EPS) of $3.68, exceeding analysts' expectations, and projected an FY 2025 EPS guidance of 14.300-14.450.
• The company also declared a quarterly dividend of $1.04 per share, resulting in an annualized dividend of $4.16 and a yield of 2.2%.

GC Wealth Management RIA LLC purchased a new position in Becton, Dickinson and Company (NYSE:BDX - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,713 shares of the medical instruments supplier's stock, valued at approximately $295,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Rempart Asset Management Inc. lifted its stake in shares of Becton, Dickinson and Company by 18.6% in the second quarter. Rempart Asset Management Inc. now owns 98,414 shares of the medical instruments supplier's stock worth $16,952,000 after buying an additional 15,417 shares in the last quarter. Camelot Portfolios LLC purchased a new position in shares of Becton, Dickinson and Company in the second quarter worth about $647,000. Argus Investors Counsel Inc. lifted its stake in shares of Becton, Dickinson and Company by 19.9% in the second quarter. Argus Investors Counsel Inc. now owns 2,530 shares of the medical instruments supplier's stock worth $436,000 after buying an additional 420 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of Becton, Dickinson and Company by 11.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 887,913 shares of the medical instruments supplier's stock worth $152,943,000 after buying an additional 89,559 shares in the last quarter. Finally, Avior Wealth Management LLC lifted its stake in shares of Becton, Dickinson and Company by 2,934.1% in the second quarter. Avior Wealth Management LLC now owns 7,919 shares of the medical instruments supplier's stock worth $1,364,000 after buying an additional 7,658 shares in the last quarter. 86.97% of the stock is owned by hedge funds and other institutional investors.

Becton, Dickinson and Company Price Performance

Shares of BDX opened at $190.90 on Thursday. Becton, Dickinson and Company has a 1-year low of $163.33 and a 1-year high of $251.99. The stock has a market cap of $54.72 billion, a PE ratio of 34.33, a P/E/G ratio of 1.51 and a beta of 0.25. The firm has a 50-day simple moving average of $188.71 and a two-hundred day simple moving average of $188.20. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.10 and a quick ratio of 0.62.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $3.68 earnings per share for the quarter, beating analysts' consensus estimates of $3.40 by $0.28. Becton, Dickinson and Company had a net margin of 7.51% and a return on equity of 16.23%. The business had revenue of $5.51 billion during the quarter, compared to analysts' expectations of $5.50 billion. During the same period last year, the business earned $3.50 earnings per share. The business's revenue for the quarter was up 10.4% on a year-over-year basis. Becton, Dickinson and Company has set its FY 2025 guidance at 14.300-14.450 EPS. As a group, analysts forecast that Becton, Dickinson and Company will post 14.43 EPS for the current year.

Becton, Dickinson and Company Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Monday, September 8th were given a dividend of $1.04 per share. The ex-dividend date was Monday, September 8th. This represents a $4.16 dividend on an annualized basis and a dividend yield of 2.2%. Becton, Dickinson and Company's dividend payout ratio (DPR) is currently 74.82%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on BDX shares. Piper Sandler reissued a "neutral" rating and issued a $200.00 price target (up from $185.00) on shares of Becton, Dickinson and Company in a research note on Friday, August 8th. Morgan Stanley lifted their target price on shares of Becton, Dickinson and Company from $196.00 to $197.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Wall Street Zen raised shares of Becton, Dickinson and Company from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Royal Bank Of Canada started coverage on shares of Becton, Dickinson and Company in a research note on Thursday, September 25th. They set a "sector perform" rating and a $211.00 target price on the stock. Finally, Wells Fargo & Company lifted their target price on shares of Becton, Dickinson and Company from $172.00 to $184.00 and gave the stock an "equal weight" rating in a research note on Friday, August 8th. Three analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $205.40.

Insider Transactions at Becton, Dickinson and Company

In other Becton, Dickinson and Company news, Director Claire Fraser sold 917 shares of Becton, Dickinson and Company stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $187.50, for a total transaction of $171,937.50. Following the completion of the sale, the director directly owned 22,226 shares in the company, valued at $4,167,375. This trade represents a 3.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael David Garrison sold 1,185 shares of Becton, Dickinson and Company stock in a transaction dated Friday, July 18th. The shares were sold at an average price of $180.29, for a total transaction of $213,643.65. Following the sale, the executive vice president owned 4,887 shares of the company's stock, valued at approximately $881,077.23. This represents a 19.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 3,023 shares of company stock valued at $562,036. Company insiders own 0.36% of the company's stock.

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.